Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 34Thoracic 30Gastrointestinal 21Breast 18Head & Neck 8Tumor-Agnostic 6Genitourinary 6Dermatologic 4Sarcoma 2Other solid neoplasm 2CNS 1

Conditions

Advanced Solid Tumour 2

Interventions

pembrolizumab 7Specimen Handling 7tislelizumab 6Cisplatin 6Carboplatin 6atezolizumab 5Pemetrexed 5Bevacizumab 5Platinum 4Interviews as Topic 4Injections 4Educational Status 4Cyclophosphamide 4Biopsy 4fludarabine 3Nivolumab 3Methods 3Magnetic Resonance Spectroscopy 3Fluorouracil 3Early Intervention, Educational 31,2-diaminocyclohexaneplatinum II citrate 3sintilimab 2sacituzumab govitecan 2X-Rays 2Trastuzumab 2Standard of Care 2Radiotherapy 2Radiation 2Practice Guidelines as Topic 2Palliative Care 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Paclitaxel × Other solid neoplasm × 30 days × Clear all
NCT06783647 2026-05-18

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

Nanjing Leads Biolabs Co.,Ltd

Phase 2 Recruiting
230 enrolled
Other solid neoplasm

Advanced Solid Tumour

NCT07331155 2026-05-18

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

Nanjing Leads Biolabs Co.,Ltd

Phase 2 Recruiting
110 enrolled
Other solid neoplasm

Advanced Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡